Effects of liraglutide on cardiovascular events in patients with type 2 diabetes and polyvascular disease: results of the LEADER trial

被引：0
|
作者：
Zinman, B. [1 ]
Verma, S. [2 ]
Bhatt, D. L. [3 ,4 ]
Bain, S. C. [5 ]
Mann, J. [6 ]
Nauck, M. A. [7 ]
Pratley, R. E. [8 ]
Michelsen, M. M. [9 ]
Fries, T. Monk [9 ]
Rasmussen, S. [9 ]
Leiter, L. A. [2 ]
机构：
[1] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hosp, Toronto, ON, Canada
[2] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[3] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Boston, MA USA
[5] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales
[6] Friedrich Alexander Univ Erlangen, Erlangen, Germany
[7] Ruhr Univ Bochum, St Josef Hosp, Diabet Ctr Bochum Hattingen, Bochum, Germany
[8] Florida Hosp, Translat Res Inst, Orlando, FL USA
[9] Novo Nordisk AS, Soborg, Denmark
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1139
引用
收藏
页码：S555 / S556
页数：2
相关论文
共 50 条
  • [31] Follow the LEADER-Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
    Kalra, Sanjay
    DIABETES THERAPY, 2016, 7 (04) : 601 - 609
  • [32] Practice pearl: liraglutide and cardiovascular and renal events in type 2 diabetes
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2018, 130 (02) : 154 - 158
  • [33] Effects of Liraglutide on Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Sotiropoulos, Alexios
    Papazafiropoulou, Athanasia
    Kokolaki, Anthi
    Kardara, Marina
    Apostolou, Ourania
    Bousboulas, Stavros
    Pappas, Stavros
    DIABETES, 2013, 62 : A662 - A663
  • [34] Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial
    Verma, Subodh
    Poulter, Neil R.
    Bhatt, Deepak L.
    Bain, Stephen C.
    Buse, John B.
    Leiter, Lawrence A.
    Nauck, Michael A.
    Pratley, Richard E.
    Zinman, Bernard
    Orsted, David D.
    Fries, Tea Monk
    Rasmussen, Soren
    Marso, Steven P.
    CIRCULATION, 2018, 138 (25) : 2884 - 2894
  • [35] Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)
    Meier, J. J.
    Nitschmann, S.
    INTERNIST, 2017, 58 (03): : 303 - 305
  • [36] COMMENT ON NAUCK ET AL. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920
    Skelin, Marko
    Rahelic, Dario
    Skelin, Petar
    Lucijanic, Marko
    DIABETES CARE, 2020, 43 (02) : E28 - E29
  • [37] Effect of liraglutide on cardiovascular outcomes in elderly patients in the LEADER trial
    Gilbert, M. P.
    Bain, S. C.
    Franek, E.
    Jodar-Gimeno, E.
    Nauck, M. A.
    Pratley, R. E.
    Rea, R.
    Saraiva, J.
    Rasmussen, S.
    Tornoe, K.
    von Scholten, B.
    Buse, J.
    DIABETOLOGIA, 2018, 61 : S368 - S369
  • [38] Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use: Results From the LEADER Trial
    Verma, Subodh
    Leiter, Lawrence A.
    Mazer, C. David
    Bain, Stephen C.
    Buse, John
    Marso, Steve
    Nauck, Michael
    Zinman, Bernard
    Bosch-Traberg, Heidrun
    Rasmussen, Soren
    Michelsen, Marie M.
    Bhatt, Deepak L.
    CIRCULATION, 2018, 138 (15) : 1605 - 1607
  • [39] EFFECT OF LIRAGLUTIDE ON CARDIOVASCULAR OUTCOMES IN ELDERLY PATIENTS IN THE LEADER TRIAL
    Gilbert, Matthew
    Bain, Stephen
    Franek, Edward
    Jodar-Gimeno, Esteban
    Nauck, Michael
    Pratley, Richard
    Rea, Rosangela
    Saraiva, Jose
    Rasmussen, Soren
    Tornoe, Karen
    von Scholten, Bernt Johan
    Buse, John B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1718 - 1718
  • [40] Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER™) Trial: Rationale and Study Design
    Bergenstal, Richard
    Daniels, Gilbert
    Mann, Johannes
    Nissen, Steven
    Pocock, Stuart
    Zinman, Bernard
    Buse, John
    Moses, Alan
    Zychma, Marcin
    Marso, Steven
    DIABETES, 2011, 60 : A612 - A613
12345